Kamada (KMDA) Depreciation & Amortization - Total (2012 - 2025)
Kamada's (KMDA) quarterly Depreciation & Amortization - Total came in at $3.8 million in Q4 2025, up 8.32% on a YoY basis from $3.5 million in Q4 2024, and up 8.32% quarter-over-quarter from $3.5 million in Q4 2024.
Analysis
Kamada (KMDA) Depreciation & Amortization - Total (2012 - 2025) Analysis & Trends
Kamada (KMDA) has reported Depreciation & Amortization - Total for 12 consecutive years, with $3.8 million the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Depreciation & Amortization - Total rose 8.32% year-over-year to $3.8 million; the trailing twelve-month figure through Dec 2025 stood at $13.5 million (up 7.26% YoY), and the FY2025 full-year result was $14.9 million, up 12.91% from the prior year.
- Depreciation & Amortization - Total improved to $3.8 million in Q4 2025 per KMDA's latest filing, from $3.5 million in the prior quarter.
- Across five years, Depreciation & Amortization - Total topped out at $3.8 million in Q4 2025 and bottomed at $1.1 million in Q1 2021.
- Historically, Depreciation & Amortization - Total has averaged $2.8 million across 5 years, with a median of $3.0 million in 2022.
- The sharpest annual moves came in 2022 and 2023: Depreciation & Amortization - Total jumped 151.61% in 2022, then rose 6.51% in 2023.
- Over 5 years, Depreciation & Amortization - Total stood at $2.0 million in 2021, then jumped by 50.83% to $3.0 million in 2022, then advanced by 6.51% to $3.2 million in 2023, then advanced by 9.41% to $3.5 million in 2024, then gained by 8.32% to $3.8 million in 2025.
- According to Business Quant data, Depreciation & Amortization - Total over the past three periods registered $3.8 million, $3.5 million, and $3.2 million for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Tot) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.77 Bn | 197.79 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 181.13 Bn | 177.95 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 132.24 Bn | 124.39 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.89 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 61.56 Bn | 56.38 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.38 Bn | 49.24 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 34.44 Bn | 31.13 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.17 Bn | 29.89 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 30.12 Bn | 30.12 Bn | 1.16 Mn | - |
| 10 | Kamada | 473.28 Mn | 403.14 Mn | 22.47 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 3.80 Mn |
| Dec 31, 2024 | 3.51 Mn |
| Dec 31, 2023 | 3.21 Mn |
| Dec 31, 2022 | 3.01 Mn |
| Mar 31, 2022 | 2.89 Mn |
| Dec 31, 2021 | 2.00 Mn |
| Mar 31, 2021 | 1.15 Mn |
| Dec 31, 2020 | 1.27 Mn |
| Sep 30, 2020 | 1.25 Mn |
| Jun 30, 2020 | 1.19 Mn |
| Dec 31, 2019 | 1.14 Mn |
| Sep 30, 2019 | 1.13 Mn |
| Jun 30, 2019 | 1.12 Mn |
| Jun 30, 2016 | 1.71 Mn |
| Mar 31, 2016 | 831,000.00 |
| Sep 30, 2015 | 2.44 Mn |
| Jun 30, 2015 | 1.57 Mn |
| Mar 31, 2015 | 771,000.00 |
| Sep 30, 2014 | 2.04 Mn |
| Jun 30, 2014 | 1.32 Mn |